Pharmos neurological, cardiovascular, autoimmune/inflammation news

PARS said it may cut 20% of its discovery and early-stage research staff to 53 from 65 to reduce its 2003 burn rate by $1 million. At the end of 2002, the company had a net loss of $17 million. ...